These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21870995)

  • 21. Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis.
    Dong H; Strome SE; Matteson EL; Moder KG; Flies DB; Zhu G; Tamura H; Driscoll CL; Chen L
    J Clin Invest; 2003 Feb; 111(3):363-70. PubMed ID: 12569162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma.
    Thompson RH; Gillett MD; Cheville JC; Lohse CM; Dong H; Webster WS; Chen L; Zincke H; Blute ML; Leibovich BC; Kwon ED
    Cancer; 2005 Nov; 104(10):2084-91. PubMed ID: 16208700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance and regulation of the costimulatory molecule B7-H1 in pancreatic cancer.
    Loos M; Giese NA; Kleeff J; Giese T; Gaida MM; Bergmann F; Laschinger M; W Büchler M; Friess H
    Cancer Lett; 2008 Sep; 268(1):98-109. PubMed ID: 18486325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B7-H1 glycoprotein blockade: a novel strategy to enhance immunotherapy in patients with renal cell carcinoma.
    Thompson RH; Webster WS; Cheville JC; Lohse CM; Dong H; Leibovich BC; Kuntz SM; Sengupta S; Kwon ED; Blute ML
    Urology; 2005 Nov; 66(5 Suppl):10-4. PubMed ID: 16194701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PI(3) kinase is associated with a mechanism of immunoresistance in breast and prostate cancer.
    Crane CA; Panner A; Murray JC; Wilson SP; Xu H; Chen L; Simko JP; Waldman FM; Pieper RO; Parsa AT
    Oncogene; 2009 Jan; 28(2):306-12. PubMed ID: 18850006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-expressed B7-H1 and B7-DC in relation to PD-1+ T-cell infiltration and survival of patients with cervical carcinoma.
    Karim R; Jordanova ES; Piersma SJ; Kenter GG; Chen L; Boer JM; Melief CJ; van der Burg SH
    Clin Cancer Res; 2009 Oct; 15(20):6341-7. PubMed ID: 19825956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B7-H1 up-regulation on dendritic-like leukemia cells suppresses T cell immune function through modulation of IL-10/IL-12 production and generation of Treg cells.
    Ge W; Ma X; Li X; Wang Y; Li C; Meng H; Liu X; Yu Z; You S; Qiu L
    Leuk Res; 2009 Jul; 33(7):948-57. PubMed ID: 19233469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma.
    Strome SE; Dong H; Tamura H; Voss SG; Flies DB; Tamada K; Salomao D; Cheville J; Hirano F; Lin W; Kasperbauer JL; Ballman KV; Chen L
    Cancer Res; 2003 Oct; 63(19):6501-5. PubMed ID: 14559843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B7-H1 up-regulation impairs myeloid DC and correlates with disease progression in chronic HIV-1 infection.
    Wang X; Zhang Z; Zhang S; Fu J; Yao J; Jiao Y; Wu H; Wang FS
    Eur J Immunol; 2008 Nov; 38(11):3226-36. PubMed ID: 18924219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of B7-H1 in pancreatic carcinoma immune evasion].
    Huang DS; Liu JW; Geng L; Jiang GP; Shen GL; Yao WF
    Zhonghua Wai Ke Za Zhi; 2009 Feb; 47(4):282-5. PubMed ID: 19570392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B7-h1 as a biomarker for therapy failure in patients with favorable histology Wilms tumor.
    Routh JC; Grundy PE; Anderson JR; Retik AB; Kurek KC
    J Urol; 2013 Apr; 189(4):1487-92. PubMed ID: 23154206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion.
    Blank C; Mackensen A
    Cancer Immunol Immunother; 2007 May; 56(5):739-45. PubMed ID: 17195077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B7-H1 overexpression regulates epithelial-mesenchymal transition and accelerates carcinogenesis in skin.
    Cao Y; Zhang L; Kamimura Y; Ritprajak P; Hashiguchi M; Hirose S; Azuma M
    Cancer Res; 2011 Feb; 71(4):1235-43. PubMed ID: 21159661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression.
    Konishi J; Yamazaki K; Azuma M; Kinoshita I; Dosaka-Akita H; Nishimura M
    Clin Cancer Res; 2004 Aug; 10(15):5094-100. PubMed ID: 15297412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Keratinocyte-associated B7-H1 directly regulates cutaneous effector CD8+ T cell responses.
    Ritprajak P; Hashiguchi M; Tsushima F; Chalermsarp N; Azuma M
    J Immunol; 2010 May; 184(9):4918-25. PubMed ID: 20363965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-17-educated monocytes suppress cytotoxic T-cell function through B7-H1 in hepatocellular carcinoma patients.
    Zhao Q; Xiao X; Wu Y; Wei Y; Zhu LY; Zhou J; Kuang DM
    Eur J Immunol; 2011 Aug; 41(8):2314-22. PubMed ID: 21674477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.
    Curiel TJ; Wei S; Dong H; Alvarez X; Cheng P; Mottram P; Krzysiek R; Knutson KL; Daniel B; Zimmermann MC; David O; Burow M; Gordon A; Dhurandhar N; Myers L; Berggren R; Hemminki A; Alvarez RD; Emilie D; Curiel DT; Chen L; Zou W
    Nat Med; 2003 May; 9(5):562-7. PubMed ID: 12704383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoregulatory role of B7-H1 in chronicity of inflammatory responses.
    Dong H; Chen X
    Cell Mol Immunol; 2006 Jun; 3(3):179-87. PubMed ID: 16893498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy.
    Wu X; Li Y; Liu X; Chen C; Harrington SM; Cao S; Xie T; Pham T; Mansfield AS; Yan Y; Kwon ED; Wang L; Ling K; Dong H
    Heliyon; 2018 Dec; 4(12):e01039. PubMed ID: 30603685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.